Note 2. Investments and loan advances due from subsidiaries
|Investments in subsidiaries||Loan advances subsidiaries||Total|
|Balance January 1, 2014||1,206,249||40,310||1,246,559|
|Net result of subsidiaries||132,843||–||132,843|
|Other comprehensive income investments||(2,179)||–||(2,179)|
|Issuance of loans||–||218||218|
|Foreign currency translation effect||150,982||5,406||156,388|
|Balance December 31, 2014||1,467,921||45,934||1,513,855|
|Net result of subsidiaries||134,504||–||134,504|
|Other comprehensive income investments||567||–||567|
|Repayments of loans||–||(2,223)||(2,223)|
|Foreign currency translation effect||132,920||5,247||138,167|
|Balance December 31, 2015||1,695,681||48,958||1,744,639|
The interest on the loan to subsidiaries is based on the Bank of America's prime rate with a rise of 2 percent points. The repayment schedule of the loan is as follows: 24 annual installments of US$2 million, starting December 31, 2018 followed by a final installment of US$5.3 million on December 31, 2043.
ASMI's share in the negative equity of an equity investment as per December 31, 2015 amounts to €(1,097), ASMI's share in the net loss for the year 2015 of the same equity investments amounts to €(900). The investment is valued at nil since the are no liabilities for ASMI.